Visiongain Publishes Cold Laser Therapy Market Report 2021-2031

03 December 2020
Pharma

Visiongain has published a new report on Cold Laser Therapy Market Report 2021-2031: Forecasts by Product (Instruments, and Accessories), by Application (Orthopedics, Dermatology, Dentistry, Neurology, Laser Acupuncture, Gynecology, and Others), by End-User (Hospitals, Homecare, Specialty Clinics, and Others), by Distribution Channel (Hospital Pharmacy, Retail pharmacy, Ecommerce and Others), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Cold Laser Therapy market was valued at US$ xx Million in 2020 and is projected to reach at a market value of US$ xx Million by 2031. North America dominated the global Cold Laser Therapy market and is projected to witness CAGR of XX% during the first half of the forecast period i.e. 2021 to 2031.

COVID-19 Impact on Cold Laser Therapy Market
COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Cold Laser Therapy market. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analysed herein the report are mentioned below:

Market Drivers

Increasing Prevalence of Chronic and Non-Chronic Diseases
Prevalence of chronic and non-chronic diseases is increasing significantly due to rapidly changing lifestyle and increased consumption of malnutrition and smoking, tobacco, alcohol, less physical activity and others. Increasing prevalence of chronic and non-chronic diseases are creating a huge demand for the cold laser therapy as cold laser therapy is used for the treatment of various chronic and non-chronic diseases. Due to this reason increasing prevalence of chronic and non-chronic diseases around the world is working as a driver for the cold laser therapy market.

Increasing Geriatric Population around the World
Number of geriatric population is increasing very fast around the world. The region is facing rapid increase in the geriatric population. For instance: According to United Nations, Department of Economic and Social Affairs, Population Division geriatric population (persons aged 65 or over) was 702.9 million in 2019. Geriatric population are at high risk of developing muscle pain and wrinkle. Continuous increase in number of the geriatric population around the world is increasing the demand for cold laser therapy around the world as the cold laser therapy is used for skin rejuvenation, physical therapy practices as treatment for muscle pain. Due to which increasing geriatric population around the world is working as a driver for the cold laser therapy market.

Market Opportunities

Increasing Technological Advancements
Cold laser therapy is used for many applications such as acupuncture, wound healing, skin rejuvenation, aches and pains, inflammation, injuries and sprains and others. Researchers are conducting various research studies to develop new potential usage in traumatic brain injury (TBI), spinal cord injury, Alzheimer’s disease, Parkinson’s disease. Research and development activities for new potential usage are expected to help to increase demand of cold laser therapy. Currently, many of the manufacturers have launched their research studies for new cold laser therapy usage which is expected to create new opportunities for cold laser therapy market.

Competitive Landscape
Top companies (THOR Photomedicine Ltd, Erchonia Corporation, Theralase Technologies, Inc. and BioLight Technologies, LLC) constitute more than XX% share of the global Cold Laser Therapy market. Other companies profiled in the report include: Apira Science, Meditech International, Inc., DJO Global, Inc., BTL, Good Energies, Irradia among others Some of the key developments are listed below:

In 2019, Melbourne, FL has received U.S. Food and Drug Administration (FDA) approval for FX 635 low-level laser for the temporary relieving form chronic, nociceptive musculoskeletal pain. The approval will help company to increase its presence in the market.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever